Use of difluoromethylornithine (DFMO, eflornithine) for late-stage African trypanosomiasis.
D000818:Animals; D002493:Central Nervous System Diseases / Q000188:drug therapy; D000518:Eflornithine / Q000627:therapeutic use*; D006801:Humans; D051379:Mice; D014353:Trypanosomiasis, African / Q000188:drug therapy*
D000518:Eflornithine